Just as obesity has been identified as a factor leading to the onset of T2DM, other metabolic impairments might have also prevented the catabolism of amino acids, enhanced insulin secretion, and increased amino acid concentration in the plasma. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.